Long-term efficacy and safety of Control-IQ technology in younger children with type 1 diabetes in Italy (2020–2023): a longitudinal multicentre real-world studyResearch in context

Summary: Background: Automated insulin delivery (AID) systems have demonstrated significant improvements in glycemic control in children and adults with type 1 diabetes, but long-term real-world data in preschool-aged children remain limited, particularly in Europe, where Control-IQ is not approved...

詳細記述

書誌詳細

主要な著者:	Valentino Cherubini, Roberto Franceschi, Andrea Fargalli, Marta Bassi, Riccardo Bonfanti, Giulia Bracciolini, Barbara Felappi, Riccardo Foglino, Dario Iafusco, Anna Lasagni, Bruno Bombaci, Claudio Maffeis, Giulio Maltoni, Chiara Mameli, Enza Mozzillo, Nicola Minuto, Barbara Piccini, Lara Devilli, Giulia Pezzino, Carmelo Pistone, Elena Prandi, Ivana Rabbone, Andrea Scaramuzza, Sara Santarelli, Francesca Silvestri, Riccardo Schiaffini, Valentina Tiberi, Davide Tinti, Marco Marigliano, Rosaria Gesuita, Donatella Lo Presti, Elvira Piccinno, Francesca Franco, Valeria De Donno, Petra Reinstadler, Silvia Sordelli, Vanna Graziani, Rosalia Roppolo, Anna Giulia Lambertini, Barbara Predieri, Emioli Randazzo, Elisabetta Delduca, Benedetta Vestrucci, Marilea Lezzi, Maurizio Delvecchio, Antonio Iannilli
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2026-03-01
シリーズ:	EClinicalMedicine
主題:	Control-IQ Automatic insulin delivery Younger children Type 1 diabetes
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2589537026000763
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!